La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « PascalFr.i » - entrée « Lévodopa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Lésion < Lévodopa < Lévétiracétam  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 133.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000014 (2014) Nicolas Morin [Canada] ; Vincent A. Jourdain ; Thérèse Di PaoloModeling dyskinesia in animal models of Parkinson disease : ANIMAL MODELS OF PARKINSON'S DISEASE
000017 (2014) Damian M. Herz [Allemagne, Danemark] ; Hartwig R. Siebner [Danemark] ; Oliver J. Hulme [Danemark] ; Esther Florin [Allemagne, Canada] ; Mark S. Christensen [Danemark] ; Lars Timmermann [Allemagne]Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease
000044 (2013) James B. Koprich [Canada] ; Philippe Huot [Canada] ; Susan H. Fox [Canada] ; Keith Jarvie [Canada] ; Anthony E. Lang [Canada] ; Philip Seeman [Canada] ; Jonathan M. Brotchie [Canada]The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques
000087 (2013) Jolyn N. A. D'Andrea [Canada] ; Angela M. Haffenden [Canada] ; Sarah Furtado [Canada] ; Oksana Suchowersky [Canada] ; Bradley G. Goodyear [Canada]Degradation of stored movement representations in the parkinsonian brain and the impact of levodopa
000095 (2013) Christopher Kobylecki [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada]Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia
000135 (2012) Lars Timmermann [Allemagne] ; Esther Florin [Allemagne, Canada]Parkinson's disease and pathological oscillatory activity: Is the beta band the bad guy? - New lessons learned from low-frequency deep brain stimulation
000140 (2012) Behzad Elahi [Canada] ; Nicolás Phielipp [Canada] ; Robert Chen [Canada]N-Methyl-D-Aspartate Antagonists in Levodopa Induced Dyskinesia: A Meta- Analysis
000149 (2012) Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Increased Levels of 5-HT1A Receptor Binding in Ventral Visual Pathways in Parkinson's Disease
000173 (2012) Golnasim Riahi [Canada] ; Marc Morissette [Canada] ; Daniel Levesque [Canada] ; Claude Rouillard [Canada] ; Pershia Samadi [Canada] ; Martin Parent [Canada] ; Thérèse Di Paolo [Canada]Effect of chronic L-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain
000184 (2012) Rena K. Mann [Canada] ; Roderick Edwards [Canada] ; JULIE ZHOU [Canada] ; Alison Fenney [Canada] ; Mandar Jog [Canada] ; Christian Duval [Canada]Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia
000202 (2012) Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale
000203 (2011) C. Paquette [États-Unis] ; E. Franzen [États-Unis, Suède] ; G. M. Jones [Canada] ; F. B. Horak [États-Unis]WALKING IN CIRCLES: NAVIGATION DEFICITS FROM PARKINSON'S DISEASE BUT NOT FROM CEREBELLAR ATAXIA
000216 (2011) James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]The Selective Mu-Opioid Receptor Antagonist ADL5510 Reduces Levodopa-Induced Dyskinesia Without Affecting Antiparkinsonian Action in MPTP-Lesioned Macaque Model of Parkinson's Disease
000218 (2011) Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease
000228 (2011) Diego Santos-Garcia [Espagne] ; Mercedes Macias [Espagne] ; Miguel Llaneza [Espagne] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernandez [Canada]Serum Vitamin B12 and Folate Levels in Parkinson's Disease Patients Treated with Duodenal Levodopa Infusion
000253 (2011) Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche]Milestones in Parkinson's Disease Therapeutics
000256 (2011) Bazoumana Ouattara [Canada] ; Laurent Gregoire [Canada] ; Marc Morissette [Canada] ; Fabrizio Gasparini [Suisse] ; Ivo Vranesic [Suisse] ; Graeme Bilbe [Suisse] ; Donald R. Johns [Suisse] ; Alex Rajput [Canada] ; Oleh. Hornykiewicz [Autriche] ; Ali H. Rajput [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Therese Di Paolo [Canada]Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
000293 (2011) A. Q. Rana [Canada] ; J. Depradine [Canada]Abdominal Pain: A Symptom of Levodopa End of Dose Wearing off in Parkinson's Disease
000294 (2011) Daniela Berg [Allemagne] ; Jana Godau [Allemagne] ; Claudia Trenkwalder [Allemagne] ; Karla Eggert [Allemagne] ; Ilona Csoti [Allemagne] ; Alexander Storch [Allemagne] ; Heiko Huber [Allemagne] ; Monica Morelli-Canelo [Allemagne] ; Maria Stamelou [Allemagne] ; Vincent Ries [Allemagne] ; Martin Wolz [Allemagne] ; Christine Schneider [Allemagne] ; Therese Di Paolo [Canada] ; Fabrizio Gasparini [Suisse] ; Sam Hariry [Suisse] ; Marc Vandemeulebroecke [Suisse] ; Walid Abi-Saab [Suisse] ; Katy Cooke [Royaume-Uni] ; Donald Johns [Suisse] ; Baltazar Gomez-Mancilla [Suisse]AFQ056 Treatment of Levodopa-Induced Dyskinesias: Results of 2 Randomized Controlled Trials
000302 (2010) Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]The α2 Adrenergic Antagonist Fipamezole Improves Quality of Levodopa Action in Parkinsonian Primates
000308 (2010) Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada]Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/PascalFr.i -k "Lévodopa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/PascalFr.i  \
                -Sk "Lévodopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Lévodopa
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022